Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Pharmacokinetics and Pharmacodynamics of a Single Dose of IPX203 in Patients With Advanced Parkinson's Disease

NCT02271503 is registered in ClinicalTrials.gov with Impax Laboratories, LLC as lead sponsor.

NCT NCT02271503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02271503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Pharmacokinetics and Pharmacodynamics of a Single Dose of IPX203 in Patients With Advanced Parkinson's Disease
Lead sponsor
Impax Laboratories, LLC
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2015
Completion date
August 31, 2016
Enrollment
26 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease